|
ИСТИНА |
Войти в систему Регистрация |
ИПМех РАН |
||
Effect of recombinant BMP-2 and erythropoietin on osteogenic properties of biomimetic PLA/PCL/HA and PHB/HA scaffolds in critical-size cranial defects modelстатья
Информация о цитировании статьи получена из
Scopus
Статья опубликована в журнале из списка Web of Science и/или Scopus
Дата последнего поиска статьи во внешних источниках: 3 мая 2024 г.
- Авторы: Senatov Fedor, Zimina Anna, Chubrik Alexander, Kolesnikov Evgeniy, Permyakova Elizaveta, Voronin Andrei, Poponova Maria, Orlova Polina, Grunina Tatyana, Nikitin Kirill, Krivozubov Mikhail, Strukova Natalia, Generalova Maria, Ryazanova Anna, Manskikh Vasily, Lunin Vladimir, Gromov Alexander, Karyagina Anna
- Журнал: Biomaterials Advances
- Том: 135
- Год издания: 2022
- Издательство: Elsevier Inc.
- Местоположение издательства: США
- Номер статьи: 112680
- DOI: 10.1016/j.msec.2022.112680
- Аннотация: Osteoplastic materials PLA/PCL/HA and PHB/HA and scaffolds with a highly porous structure based on them with potential applications in regenerative medicine have been obtained by solvent casting with thermopressing and salt leaching for PLA-based samples and solid-state mixing with subsequent thermopressing and salt leaching for PHB-based samples. The scaffolds were characterized by SEM-EDX, DSC, FTIR spectroscopy, mechanical tests in compression, measurement of the contact angle, in vitro studies, including loading by recombinant BMP-2 and EPO and their release kinetics, and in vivo studies on a model of regeneration of critical-sized cranial defects in mice. Biomimetic scaffolds with micropores sizes ranged from 300 to 500 μm and volume porosity of 70% imitate trabecular bone's structure and have increased hydrophilicity to achieve osteoconductive properties. Mechanical characteristics correspond to native trabecular bone. Elastic modulus – key mechanical characteristics of bone implants – showed the values of 0.15 ± 0.04 and 0.18 ± 0.08 GPa for PLA/PCL/HA and PHB/HA scaffolds, respectively. Both materials have high biocompatibility and can be used together with recombinant proteins BMP-2 and EPO. Introduction of BMP-2 leads to induction of new bone formation, introduction of EPO results in increased angiogenesis in the implantation area. The obtained scaffolds with recombinant proteins can be used as bone implants for reconstruction of defects of lightly or non-loaded bones.
- Добавил в систему: Карягина-Жулина Анна Станиславовна